IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Miragen Therapeutics Inc

CUSIP: 60463E10E | 1 institutional holders

Quarters

Q1 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2018

Opaleye Management Inc.1,060,000
0.0% of portfolio›$7.4K
StyleTurnoverLocationFiled
Opaleye Management Inc.
1,060,000$7.4K0.0%Agg GrowthMediumBoston, MA2018-05-14